Geode Capital Management
HOWL icon

Geode Capital Management’s Werewolf Therapeutics HOWL Stock Holding History

Geode Capital Management’s Portfolio HOWL Stock Details HOWL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$121K Sell
335,815
-53,672
-14% -$32.7K ﹤0.01% 4056
2026
Q1 		$324K Buy
389,487
+53,601
+16% +$36.7K ﹤0.01% 3745
2025
Q4 		$213K Buy
335,886
+5,099
+2% +$6.2K ﹤0.01% 3883
2025
Q3 		$652K Buy
330,787
+2,832
+0.9% +$3.88K ﹤0.01% 3526
2025
Q2 		$358K Sell
327,955
-389,569
-54% -$401K ﹤0.01% 3660
2025
Q1 		$698K Buy
717,524
+14,966
+2% +$19.6K ﹤0.01% 3428
2024
Q4 		$1.04M Buy
702,558
+16,569
+2% +$33.8K ﹤0.01% 3365
2024
Q3 		$1.45M Buy
685,989
+40,692
+6% +$92.6K ﹤0.01% 3224
2024
Q2 		$1.57M Buy
645,297
+385,617
+148% +$1.85M ﹤0.01% 3177
2024
Q1 		$1.68M Buy
259,680
+65,372
+34% +$381K ﹤0.01% 3180
2023
Q4 		$750K Buy
194,308
+20,058
+12% +$51.2K ﹤0.01% 3458
2023
Q3 		$373K Buy
174,250
+8,935
+5% +$24.6K ﹤0.01% 3717
2023
Q2 		$504K Buy
165,315
+35,483
+27% +$99.9K ﹤0.01% 3638
2023
Q1 		$338K Hold
129,832
– – ﹤0.01% 3806
2022
Q4 		$266K Buy
129,832
+9,545
+8% +$25K ﹤0.01% 3945
2022
Q3 		$542K Buy
120,287
+41,007
+52% +$223K ﹤0.01% 3679
2022
Q2 		$324K Sell
79,280
-209,025
-73% -$954K ﹤0.01% 3990
2022
Q1 		$1.27M Buy
288,305
+74,081
+35% +$519K ﹤0.01% 3502
2021
Q4 		$2.55M Buy
214,224
+77,752
+57% +$1.17M ﹤0.01% 3258
2021
Q3 		$2.34M Buy
136,472
+28,294
+26% +$483K ﹤0.01% 3280
2021
Q2 		$1.89M Buy
+108,178
New +$1.48M ﹤0.01% 3290

Other funds holding HOWL

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
DF
DC Funds Mclean, Virginia $1.25M AUM 26.51% 1-Year Est. Return
VA
Verdad Advisers Boston, Massachusetts $104M AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Geode Capital Management's HOWL Position: Q2 2026 in Review

Geode Capital Management reduced its Werewolf Therapeutics (HOWL) stake by 14% in Q2 2026, selling an estimated $32.7K and leaving 335,815 shares worth $121K. The position accounts for ﹤0.01% of the portfolio, ranked #4056.

Geode Capital Management first reported a position in HOWL in Q2 2021 and has held it in 21 quarters since. The position peaked at $2.55M in Q4 2021. 45 funds tracked by Wall St. Rank hold HOWL as of Q2 2026.

  • Geode Capital Management held 335,815 shares of Werewolf Therapeutics worth $121K as of Q2 2026.
  • Geode Capital Management sold 53,672 Werewolf Therapeutics shares in Q2 2026, an estimated $32.7K.
  • Werewolf Therapeutics made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #4056 holding.
  • Geode Capital Management first reported a position in Werewolf Therapeutics in Q2 2021 and has held it in 21 quarters since.
  • Geode Capital Management's Werewolf Therapeutics position peaked at $2.55M in Q4 2021.
  • 45 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.